- Report
- February 2024
- 70 Pages
Vietnam
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
South Korea
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
France
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
Germany
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
Malaysia
From €4719EUR$4,750USD£3,924GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4719EUR$4,750USD£3,924GBP
- Report
- April 2023
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- April 2023
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- April 2023
- 112 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- April 2023
- 113 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- April 2023
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- August 2022
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- August 2022
- 111 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- August 2022
- 115 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- June 2022
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- January 2022
- 115 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- January 2022
- 115 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- January 2022
- 117 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- January 2022
- 100 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- January 2022
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more